Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis
- 15 July 2013
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1290 (1), 59-66
- https://doi.org/10.1111/nyas.12145
Abstract
There are a number of pharmacological agents for the treatment of bone mineral loss and osteoporosis. Hormone replacement therapy (HRT) with estrogen is an established treatment, but it has several adverse side effects and can increase the risk of cancer, heart disease, and stroke. There is increasing interest in nutritional factors and naturally occurring phytochemical compounds with the potential for preventing age-related and postmenopausal bone loss. Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a polyphenolic phytoestrogen with osteogenic and osteoinductive properties. It can modify the metabolism of bone cells and has the capacity to modulate bone turnover. This paper provides an overview of current research on resveratrol and its effects on bone cells in vitro, highlighting the challenges and opportunities facing this area of research, especially in the context of providing nutritional support for postmenopausal women who may not benefit from HRT and older patients with various forms of arthritis, metabolic bone disease, and osteoporosis.Keywords
This publication has 42 references indexed in Scilit:
- Estrogens, osteoarthritis and inflammationJoint Bone Spine, 2013
- Bone remodelling in osteoarthritisNature Reviews Rheumatology, 2012
- Bone cells and the mechanisms of bone remodellingFrontiers in Bioscience-Elite, 2012
- The osteon: the micromechanical unit of compact boneFrontiers in Bioscience-Landmark, 2012
- Bone Mineral Density in Estrogen-Deficient Young WomenJournal of Clinical Endocrinology & Metabolism, 2009
- Osteoporosis: non-hormonal treatmentClimacteric, 2007
- Estrogen deficiency and bone loss: an inflammatory taleJCI Insight, 2006
- Bisphosphonates: potential therapeutic agents for disease modification in osteoarthritis.Aging Clinical and Experimental Research, 2003
- Pathogenesis of osteoporosisBest Practice & Research Clinical Endocrinology & Metabolism, 2000
- The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly WomenNew England Journal of Medicine, 1993